BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10523601)

  • 1. Septicemia in neutropenic patients infected with Clostridium tertium resistant to cefepime and other expanded-spectrum cephalosporins.
    Steyaert S; Peleman R; Vaneechoutte M; De Baere T; Claeys G; Verschraegen G
    J Clin Microbiol; 1999 Nov; 37(11):3778-9. PubMed ID: 10523601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridium tertium septicemia in patients with neutropenia.
    Speirs G; Warren RE; Rampling A
    J Infect Dis; 1988 Dec; 158(6):1336-40. PubMed ID: 3198941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cluster of seven cases of Clostridium tertium septicemia in neutropenic patients.
    Valtonen M; Sivonen A; Elonen E
    Eur J Clin Microbiol Infect Dis; 1990 Jan; 9(1):40-2. PubMed ID: 2303065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridium tertium: 3 case reports.
    Leegaard TM; Sandven P; Gaustad P
    Scand J Infect Dis; 2005; 37(3):230-2. PubMed ID: 15849058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of Clostridium tertium as a pathogen in neutropenic patients.
    Thaler M; Gill V; Pizzo PA
    Am J Med; 1986 Oct; 81(4):596-600. PubMed ID: 3766589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient.
    Ramphal R; Gucalp R; Rotstein C; Cimino M; Oblon D
    Am J Med; 1996 Jun; 100(6A):83S-89S. PubMed ID: 8678102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium tertium in neutropenic patients: case series at a cancer institute.
    Shah S; Hankenson J; Pabbathi S; Greene J; Nanjappa S
    Int J Infect Dis; 2016 Oct; 51():44-46. PubMed ID: 27575937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cephalosporin Resistance in
    Wang M; Zu X; Zhao Z; Fu F; Bai X; Gong X; Zhao P; Gao W; Xue Y
    Microb Drug Resist; 2020 Oct; 26(10):1250-1259. PubMed ID: 32013730
    [No Abstract]   [Full Text] [Related]  

  • 9. The impact of cefepime as first line therapy for neutropenic fever on Clostridium difficile rates among hematology and oncology patients.
    Muldoon EG; Epstein L; Logvinenko T; Murray S; Doron SI; Snydman DR
    Anaerobe; 2013 Dec; 24():79-81. PubMed ID: 24140078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neutropenia with fever].
    Ben Ali A
    Presse Med; 1999 Nov; 28 Suppl 3():9-10. PubMed ID: 10605460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High rates of resistance to cephalosporins among viridans-group streptococci causing bacteraemia in neutropenic cancer patients.
    Marron A; Carratalà J; Alcaide F; Fernández-Sevilla A; Gudiol F
    J Antimicrob Chemother; 2001 Jan; 47(1):87-91. PubMed ID: 11152436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Practical use of cefepime in an University hospital. Retrospective study of 35 cases].
    Gérard A; Le Meins V; Maurer P; Witz B; Dopff C
    Pathol Biol (Paris); 1996 Feb; 44(2):138-40. PubMed ID: 8761599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal Clostridium tertium septicemia in a nonneutropenic patient.
    Tappe D; Dirks J; Müller R; Brederlau J; Abele-Horn M; Suerbaum S; Kurzai O
    J Infect; 2005 Jan; 50(1):76-80. PubMed ID: 15603846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breakthrough bacteremia due to Clostridium tertium in a patient with neutropenic fever, and identification by MALDI-TOF mass spectrometry.
    Salvador F; Porte L; Durán L; Marcotti A; Pérez J; Thompson L; Noriega LM; Lois V; Weitzel T
    Int J Infect Dis; 2013 Nov; 17(11):e1062-3. PubMed ID: 23823278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial empirical antimicrobial therapy: duration and subsequent modifications.
    Tamura K
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S59-64. PubMed ID: 15250024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility of Clostridium difficile isolates to 12 antimicrobial agents.
    Gianfrilli P; Luzzi I; Pantosti A; Occhionero M
    Chemioterapia; 1984 Feb; 3(1):41-4. PubMed ID: 6535652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridium tertium bacteremia: 2 cases and review.
    Gosbell IB; Johnson CG; Newton PJ; Jelfs J
    Pathology; 1996 Jan; 28(1):70-3. PubMed ID: 8714277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of cefepime alone and in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro.
    Gerber CM; Cottagnoud M; Neftel K; Täuber MG; Cottagnoud P
    J Antimicrob Chemother; 2000 Jan; 45(1):63-8. PubMed ID: 10629014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium tertium bacteremia in a leukemia patient.
    Leichtman DA; LeBar WD
    Eur J Clin Microbiol Infect Dis; 1989 Apr; 8(4):314-5. PubMed ID: 2497006
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN; Sader HS; Fritsche TR; Pottumarthy S
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.